Thermo Fisher Scientific Opens GMP-Certified Facility in the EU
Thermo Fisher Scientific has unveiled a new GMP-certified ultra-cold facility in the EU to accelerate advanced therapy development and meet rising biopharma service demands.
Location and Capabilities
The facility, located in Bleiswijk, Netherlands, is strategically positioned to support the clinical and commercial supply chain for advanced therapies. Just 30 minutes from Amsterdam, this site offers 5,000 square meters of storage space and comprehensive services including cold chain packaging, distribution, and clinical QP release. The facility’s proximity to major transportation hubs ensures efficient logistics and timely delivery of critical therapies across Europe.
Sustainability and Innovation
In line with Thermo Fisher’s commitment to sustainability, the Bleiswijk facility operates gas-free and utilizes eco-friendly heating and cooling technologies, including electric heat pumps. Additionally, it harnesses 15% solar energy, aligning with the company’s goal of achieving net-zero emissions by 2050. This emphasis on green technology not only reduces the facility’s carbon footprint but also supports global sustainability efforts.
Comprehensive Biopharma Support
The new facility is designed to provide end-to-end support for high-quality therapies such as cell and gene therapies, biological drugs, antibodies, and vaccines. According to Molly Flick, Vice President and General Manager of Bioservices & Specialty Logistics at Thermo Fisher Scientific, the facility places the company in a unique position to assist global customers in developing innovative therapies, from initial clinical trials to commercial distribution.
Global Expansion and Commitment
Thermo Fisher Scientific’s expansion in Bleiswijk is part of a broader strategy to enhance its global biopharma capabilities. The company has recently expanded its biologics manufacturing capacity in St. Louis, opened a cell therapy facility in San Francisco, and launched an innovation lab in Pennsylvania. These developments underscore Thermo Fisher’s dedication to promoting inclusive and impactful clinical research through comprehensive solutions.
Impact on Advanced Therapies
The opening of the Bleiswijk facility is a significant milestone in the development of advanced therapies. By providing state-of-the-art storage and logistics solutions, Thermo Fisher Scientific is poised to accelerate the delivery of cutting-edge treatments to patients. This facility not only enhances the company’s ability to meet the growing demand for biopharma services in Europe but also reinforces its role as a leader in the life sciences industry.